News Novartis' canakinumab cuts risk for heart attack survivors Novartis to discuss canakinumab results with regulators.
News MSD and Bayer launch big gamble on heart failure candidate Aims to recruit 4,900 patients to prove value in heart failure
News Medtronic to buy HeartWare, expand heart failure portfolio Deal worth an estimated $1.1 billion.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.